Vallon Pharmaceuticals, Inc. VLON NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

共有 49 笔近期内部人交易记录记录，涉及 Vallon Pharmaceuticals, Inc. (VLON), 包括 30 笔买入 和 8 笔卖出. 内部人买入总额为 $3M 内部人卖出总额为 $254.48K.

近期活跃的重要内部人包括 Kelly Leanne, Szekeres David Leslie, Rongen Roelof. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — VLON

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2023-09-22	Kelly Leanne	Chief Financial Officer	限制性股票授予 (RSU)	83,333	$1.52	$126.67K	83,333
2023-08-10	Szekeres David Leslie	Director	限制性股票授予 (RSU)	34,483	$2.90	$100K	34,483
2023-08-10	Rongen Roelof	Director	限制性股票授予 (RSU)	34,483	$2.90	$100K	34,483
2023-08-10	Simpson Camilla V	Director	限制性股票授予 (RSU)	34,483	$2.90	$100K	34,483
2023-08-10	Baker David Charles	Director	限制性股票授予 (RSU)	34,483	$2.90	$100K	34,483
2023-04-21	Szekeres David Leslie	Director	未知	-	-	-	-
2023-04-21	Agro Albert	Chief Medical Officer	限制性股票授予 (RSU)	172,189	-	-	172,189
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	限制性股票授予 (RSU)	385,510	-	-	385,510
2023-04-21	Chaturvedi Vipin	Chief Scientific Officer	限制性股票授予 (RSU)	172,189	-	-	172,189
2023-04-21	Agro Albert	Officer	未知	-	-	-	-
2023-04-21	Rongen Roelof	Director	未知	-	-	-	-
2023-04-21	Simpson Camilla V	Director	未知	-	-	-	-
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	未知	-	-	-	-
2023-04-21	Chaturvedi Vipin	Officer	未知	-	-	-	-
2022-12-13	Thorell Marella	Director	其他（卖出）	28,517	-	-	9,506
2022-07-01	Thorell Marella	Director	限制性股票授予 (RSU)	38,023	-	-	38,023
2022-06-09	Payne Joseph E	Director	限制性股票授予 (RSU)	7,500	-	-	7,500
2022-06-09	Thorell Marella	Director	限制性股票授予 (RSU)	7,500	$0.51	$3.83K	7,500
2022-06-09	Ammer Richard	Director	限制性股票授予 (RSU)	7,500	-	-	7,500
2022-02-23	Chhabra Meenu	Director	未知	-	-	-	-
2022-02-23	Chhabra Meenu	Director	限制性股票授予 (RSU)	15,000	$7.67	$115.05K	15,000
2022-02-15	Kelly Leanne M.	Chief Financial Officer	限制性股票授予 (RSU)	50,000	$5.63	$281.5K	50,000
2022-02-15	Baker David Charles	Chief Executive Officer	限制性股票授予 (RSU)	61,000	$5.63	$343.43K	61,000
2021-06-04	Kelly Leanne M.	Chief Financial Officer	知情买入	1,508	$4.08	$6.15K	6,250
2021-06-03	Kelly Leanne M.	Chief Financial Officer	知情买入	1,085	$4.05	$4.39K	4,742
2021-06-02	Kelly Leanne M.	Chief Financial Officer	知情买入	3,657	$4.00	$14.63K	3,657
2021-05-26	Payne Joseph E	Director	知情买入	6,800	$4.50	$30.6K	17,500
2021-05-25	Payne Joseph E	Director	知情买入	10,700	$3.85	$41.2K	10,700
2021-05-14	Kelly Leanne M.	Chief Financial Officer	限制性股票授予 (RSU)	70,000	$3.66	$256.2K	70,000
2021-05-14	Payne Joseph E	Director	限制性股票授予 (RSU)	14,286	$3.66	$52.29K	14,286
2021-05-14	Toren Penny	SVP, Regul Affairs & Prog Mgmt	限制性股票授予 (RSU)	25,000	$3.66	$91.5K	25,000
2021-05-14	Levi Ofir	Director	限制性股票授予 (RSU)	15,000	$3.66	$54.9K	15,000
2021-05-14	Ammer Richard	Director	限制性股票授予 (RSU)	10,204	$3.66	$37.35K	10,204
2021-05-14	Baker David Charles	Chief Executive Officer	限制性股票授予 (RSU)	100,000	$3.66	$366K	100,000
2021-05-11	Kelly Leanne M.	Officer	未知	-	-	-	-
2021-02-12	Thorell Marella	Director	限制性股票授予 (RSU)	15,000	$8.00	$120K	15,000
2021-02-12	Ammer Richard	Director	其他（买入）	47,063	$6.40	$301.2K	47,063
2021-02-12	Salmon Pharma Gmbh	10 Percent Owner	其他（买入）	47,063	$6.40	$301.2K	47,063
2021-02-12	Baker David Charles	Chief Executive Officer	其他（买入）	7,843	$6.40	$50.2K	7,843
2021-02-09	Thorell Marella	Director	未知	-	-	-	-
2021-02-09	Toren Penny	SVP, Regul Affairs & Prog Mgmt	处置	5,000	$3.82	$19.1K	-
2021-02-09	Levi Ofir	Director	处置	-	-	-	196,875
2021-02-09	Ammer Richard	10 Percent Owner	未知	-	-	-	1,476,734
2021-02-09	Salmon Pharma Gmbh	10 Percent Owner	处置	-	-	-	1,476,734
2021-02-09	Payne Joseph E	10 Percent Owner	未知	-	-	-	843,750
2021-02-09	Arcturus Therapeutics Holdings Inc.	10 Percent Owner	处置	-	-	-	843,750
2021-02-04	Baker David Charles	Chief Executive Officer	处置	61,250	$2.20	$134.75K	-
2019-01-15	Baker David Charles	Chief Executive Officer	处置	46,875	$1.84	$86.25K	-
2018-10-01	Toren Penny	SVP, Regul Affairs & Prog Mgmt	处置	7,813	$1.84	$14.38K	-